The Germany Quantum Computing in Healthcare Market was valued at $20 Million in 2025 and projected to reach to $100 Million by 2030, representing a compound annual growth rate of 38.0%. Germany's quantum computing in healthcare market is poised for exceptional growth as the country leverages its technological expertise and pharmaceutical leadership.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Germany's quantum computing in healthcare market is valued at $20.0 million in 2025 and is projected to reach $100.0 million by 2030, representing a 5x increase over five years.
With a compound annual growth rate of 38.0%, Germany's market growth significantly outpaces global averages, driven by robust pharmaceutical R&D investments and digital health initiatives.
Germany's world-class pharmaceutical research infrastructure and biotech ecosystem position the country as a key hub for quantum computing applications in drug discovery and development.
Germany's advanced healthcare system and commitment to digital transformation create favorable conditions for quantum computing adoption in diagnostics, personalized medicine, and clinical research.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | HEALTHCARE PAYERS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 37.9% from 2025 to 2030 |
| Largest Segment | CLOUD-BASED SOLUTIONS (Deployment) |
| Market Size Base Year (Billions) | ~USD 0.27 (2025) |
| Revenue Forecast (Billions) | ~USD 1.32 (2030) |
| Segments Covered | Component, Deployment, Technology, Application, End User |
5 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| HEALTHCARE PAYERS | 1 | 1.5 | 2.3 | 3.5 | 5.2 | 7.8 | 11.4 | 16.7 | 48.5 |
| HEALTHCARE PROVIDERS | 1.9 | 2.7 | 3.8 | 5.3 | 7.3 | 10.1 | 14 | 19.4 | 38.6 |
| LABS & RESEARCH INSTITUTES | 2.4 | 3.3 | 4.6 | 6.3 | 8.6 | 11.8 | 16.1 | 21.8 | 36.6 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 5 | 6.8 | 9.3 | 12.7 | 17.2 | 23.2 | 31.3 | 42.1 | 35.2 |
| TOTAL | 10.3 | 14.4 | 20 | 27.8 | 38.4 | 52.9 | 72.8 | 100 | 38 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| IBM | United States | ||
| MICROSOFT | United States | ||
| GOOGLE LLC | United States | ||
| ATOS SE | United States |
IBM is a multinational technology corporation that offers quantum computing systems, cloud services, and enterprise solutions across hardware, software, and infrastructure.
Microsoft is a global technology company that develops quantum computing hardware, software, and cloud services through its Azure Quantum platform.
Google LLC is a technology company that develops quantum processors, quantum algorithms, and quantum computing research through its Quantum AI division.
Atos SE is a multinational IT services company that provides quantum computing solutions, simulation software, and enterprise technology services.
Germany's quantum computing in healthcare market was valued at $20.0 million in 2025 and is projected to reach $100.0 million by 2030.
Germany's quantum computing in healthcare market is expected to grow at a compound annual growth rate (CAGR) of 38.0% from 2025 to 2030.
Germany's primary quantum computing applications in healthcare include drug discovery, molecular simulation, personalized medicine optimization, and clinical trial design.
Germany's strong pharmaceutical research infrastructure, advanced healthcare IT systems, government quantum initiatives, and leadership in precision medicine are key growth catalysts.
Germany is positioned as a leading European hub for quantum computing in healthcare, leveraging its biotech ecosystem, regulatory maturity, and significant R&D investment.
The study involved several key activities in estimating the current size of the quantum computing in healthcare market. Extensive secondary research was conducted to gather information on this market. The next step was to validate the findings, assumptions, and size estimates by consulting industry experts throughout the value chain through primary research. We employed various methods, including top-down and bottom-up approaches, to estimate the overall market size. Following this, we utilized market segmentation and data triangulation techniques to determine the size of specific segments and subsegments within the quantum computing in healthcare market.
This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing quantum computing in healthcare solutions is assessed using secondary data from both paid and free sources. This involves analyzing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the quantum computing in healthcare market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.
Primary research was conducted to identify segmentation types; industry trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.
After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of quantum computing in healthcare solutions offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.
In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
A breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by component, application, deployment, technology, end user, and region).

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the quantum computing in healthcare market.
The quantum computing in healthcare market refers to the application of quantum technologies to enhance medical research and healthcare delivery. It includes the use of quantum hardware, software, and services to accelerate tasks such as drug discovery, genetic analysis, disease modeling, and personalized treatment by processing complex data more efficiently than classical systems.
Full forecast, segment splits, and company analysis for all Quantum Computing in Healthcare Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report